Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in France / NCT07439146
Starting soon Observational

Risk of Pneumonia in Intubated Patients in Emergency Situations

NCT07439146 · tracked via the Priya Life Science France tracker
Sponsor
University Hospital, Clermont-Ferrand
Phase
Observational
Started
2026-02-09
Last updated
2026-02-27

Condition(s) studied

PneumoniaOrotracheal Intubation

Study summary

Orotracheal intubation in emergency medicine is a vital procedure for ensuring adequate oxygenation and ventilation in patients with respiratory distress or in shock. However, this procedure exposes patients to complications such as pneumonia. In the matter of fact, the urgency of the procedure means that it is not possible to wait until the patient's stomach is empty. Pneumonia significantly increase patient morbidity and mortality. Therapeutic management must be early and appropriate to improve the patient's prognosis.

The aim of this study is to compare the rate of pneumonia occurring in patients intubated in emergency situations with that in patients intubated in non-emergency situations in all 2024. Health data will only collected from patient's medical records.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Adult man or woman * Emergency and non-emergency intubated patient in 2024 * Patient hospitalized in intensive care following intubation in 2024 Exclusion Criteria: * Patient under guardianship, curatorship or safeguard of justice * Pregnant woman * Refusal to participate

Primary outcome measure(s)

  • Pneumonia rate in 48 hours after the start of orotracheal intubation. — Hour 48
    Rate of pneumonia occuring within 48 hours of the start of orotracheal intubation.

Trial sites (6)

FacilityCityRegionStatus
CH Aurillac Aurillac France
CHU de Clermont-Ferrand, Clermont-Ferrand Clermont-Ferrand France
CH du Puy en Velay Le Puy-en-Velay France
CH de Montluçon Montluçon France
CH de Moulins Moulins France
CH de Vichy Vichy France

More University Hospital, Clermont-Ferrand trials in France

Vascular Function, Sarcopenia and Pain in Postmenopausal Osteoporosis Recruiting
Prevalence of Childhood Maltreatment Among Women With Dysmenorrhea. Enrolling by invitation
Effects of Early Testosterone Gel Administration on Physical Performance in the Critically Ill Recruiting
Evaluation of a French Hospital Discharge Therapeutic Education Program by Nurses for Heart Failure Patient (EduSor) Starting soon
Efficacy of Orosol® in the Treatment of Chemo- and Radiation-induced Mucositis. Recruiting

Other trials for the same condition

Predictive Factors of Good Pulmonary Penetration of Antibiotics : AntiBiotics Dosage in Broncho-Alveolar Lavage Active, not recruiting
Study of the Characteristics of Acute Mycoplasma Resuscitation: ECRAN-PLASMA Study Active, not recruiting
Pilot Study on the Use of Video Laryngoscopy in Pre-hospital Settings Recruiting
Randomised Evaluation of COVID-19 Therapy Recruiting
Evaluation of the Relevance of Diaphragmatic Stroke Ultrasound for the Etiological Diagnosis of Acute Respiratory Distress in an Emergency Department. Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07439146 on ClinicalTrials.gov ↗ ← All trials in France